An article posted today at The Atlantic discusses fecal transplants and FDA regulation. Dr. Colleen Kraft (co-author of a paper on fecal transplant protocols that appeared in Lab Medicine) is quoted in the article, and it’s worth a read.
A study published in PLOSone back in September analyzed the microbial-fighting capability of … well, microbes. The authors evaluated the efficacy of cleaning hospital rooms with food-grade Bacillus subtilis, Bacillus pumilus, and Bacillus megaterium. The authors concluded that cleaning hospitals rooms with these organisms reduced the number of hospital-acquired-infection-causing organisms on surfaces.
It’s an intriguing idea, and not that out of the box; lots of antimicrobial agents are derived from other microorganisms (I’m looking at you, penicillin). It’ll be interesting to see where other researchers take this.
–Kelly Swails, MT(ASCP), is a laboratory professional, recovering microbiologist, and web editor for Lab Medicine.